Global Neglected Tropical Diseases Diagnosis Market to grow with a CAGR of 4.09%.
Increasing healthcare
infrastructure and a supportive regulatory environment are the major drivers
for the Global Neglected Tropical Diseases Diagnosis Market.
According to TechSci Research
report, “Global Neglected Tropical Diseases Diagnosis Market Industry Size, Share, Trends, Competition,
Opportunity and Forecast, 2018-2028”, Global Neglected Tropical
Diseases Diagnosis Market has valued at USD 6.20 billion in 2022 and is
anticipated to witness an impressive growth in the forecast period with a CAGR
of 4.09% through 2028. This can be due to collaborations and partnerships among
leading companies with a diverse approach to merge the expertise of individual
companies and to strengthen their position in the market.
The impact of Neglected
Tropical Diseases (NTDs) on Sustainable Development Goals (SDGs) drives the
demand for the Global Neglected Tropical Diseases Diagnosis Market. NTDs disproportionately
affect the world's poorest populations, trapping them in a cycle of poverty.
These diseases hinder economic development by reducing productivity and
increasing healthcare costs. Accurate diagnosis and treatment of NTDs can help
lift communities out of poverty, making it a priority to address NTDs and,
consequently, the need for diagnostic tools. NTDs can lead to malnutrition,
growth stunting, and reduced agricultural productivity, directly impacting food
security. Addressing NTDs through early diagnosis and treatment can help
improve nutritional outcomes, aligning with efforts to achieve zero hunger. Good
Health and Well-Being: SDG 3 directly relates to health, and NTDs have a
substantial impact on health outcomes. Early diagnosis is essential for
effective treatment and the prevention of complications, contributing to
improved health and well-being. Quality Education: NTDs often lead to school
absenteeism and cognitive impairments, hindering access to quality education.
By controlling and eliminating NTDs, students can attend school regularly,
driving the demand for early diagnosis and treatment. NTDs can disproportionately
affect women and girls, leading to gender disparities in health and education.
Early diagnosis and treatment can mitigate these gender inequalities and
promote gender equality. Many NTDs thrive in environments with
poor sanitation and limited access to clean water. Improved sanitation and
hygiene practices, along with early diagnosis, are crucial for NTDs control.
Browse over XX market data Figures and spread through 110 Pages and an in-depth TOC on " Global Neglected Tropical Diseases Diagnosis Market”
In the aftermath of the COVID-19 pandemic,
there was a notable decline in neglected tropical disease (NTD) diagnosis. In
2000, the World Health Organization (WHO) launched the Global Program to
Eliminate Lymphatic Filariasis (GPELF) with the goal of halting disease
transmission and alleviating the suffering of affected individuals. However, a
recent pulse survey conducted by WHO in early 2021 revealed that NTD programs
in 44% of countries have experienced disruptions. Additionally, the heightened
risk of SARS-CoV-2 transmission has impacted public health strategies for
addressing NTDs.
In May 2023, Astellas Pharma
Inc. under the leadership of President and CEO Naoki Okamura, has reaffirmed
its commitment to backing the third phase of the Global Health Innovative
Technology Fund (GHIT Fund). Astellas joins a diverse consortium of funding
partners in pledging over US$200 million to support the GHIT Fund. Remarkably,
Astellas has been a consistent contributor to the GHIT Fund since its
inception, marking its third consecutive term of support. Established in 2013,
the GHIT Fund was created with the aim of harnessing Japan's expertise and
capabilities in the realm of life-saving healthcare innovations. This includes
the development of drugs, vaccines, and diagnostics to combat infectious
diseases like tuberculosis, malaria, and neglected tropical diseases (NTDs)
that afflict some of the world's most impoverished regions. As a public
interest corporation registered in Japan, the GHIT Fund represents a pioneering
international public-private partnership (PPP) fund. It brings together key
stakeholders, including the Japanese Government (Ministry of Foreign Affairs
and Ministry of Health, Labor, and Welfare), the private sector, the Bill &
Melinda Gates Foundation, the Welcome Trust, and the United Nations Development
Programme.
Variability in disease
distribution is a challenge in the Global Neglected Tropical Diseases (NTDs)
Diagnosis Market. This variability refers to the uneven distribution of NTDs
across different regions and populations. NTDs encompass a diverse group of
diseases caused by various pathogens, and their distribution varies widely.
Some NTDs are highly localized, while others have a more widespread presence.
This heterogeneity complicates efforts to design and deploy diagnostic tools
and interventions. NTDs are often endemic in specific geographic regions. For
example, diseases like Chagas disease are primarily found in Latin America,
while African trypanosomiasis is prevalent in sub-Saharan Africa. The
geographic variability necessitates region-specific approaches to diagnosis and
control. Some NTDs, despite being localized, have the potential to cause
outbreaks and epidemics when environmental conditions are favorable. This
unpredictability challenges healthcare systems' preparedness and diagnostic
capacities. The variability in disease distribution requires targeted resource
allocation. Regions with a high burden of specific NTDs may require more
diagnostic tests and interventions, which can strain limited healthcare
resources. Developing and distributing diagnostic tests for NTDs with highly
variable distribution can be logistically challenging. Manufacturers may
prioritize diseases with larger affected populations, potentially leaving those
with localized distribution underserved.
Global Neglected
Tropical Diseases Diagnosis Market is segmented based on Disease, Diagnostic
Method, By Service Type, End-Use, and by region.
Based on Disease, Global Neglected
Tropical Diseases Diagnosis Market is segmented into Dengue, Chikungunya,
Rabies, Buruli Ulcer, Yaws, Lymphatic Filariasis, Taeniasis/Cysticercosis,
Dracunculiasis, and others. Lymphatic filariasis,
commonly known as elephantiasis, is a parasitic disease caused by microscopic
thread-like worms called filarial parasites. It is one of the Neglected
Tropical Diseases (NTDs) that primarily affects people living in tropical and
subtropical regions of the world. Lymphatic filariasis is
caused by three species of filarial worms, which are transmitted to humans
through the bites of infected mosquitoes. The three main species are Wuchereria
bancrofti, Brugia malayi, and Brugia timori. The disease is transmitted when an
infected mosquito carrying the larvae (microfilariae) of the filarial parasite
bites a human host. The larvae then enter the host's bloodstream, where they
can migrate to the lymphatic system. Lymphatic filariasis has
different forms and stages, but it primarily affects the lymphatic system,
which is a vital part of the immune system and fluid balance in the body.
Based on Region, North America dominated the Global Neglected
Tropical Diseases Diagnosis Market. North American experts in fields such as infectious
diseases, epidemiology, and diagnostics collaborate with international partners
and organizations working on NTDs. Their expertise and collaboration contribute
to advancements in NTDs diagnosis. North American organizations and advocacy
groups play a role in raising awareness about NTDs and advocating for increased
funding and support for research and diagnosis efforts. North American
countries, particularly the United States and Canada, have been active participants
in global health initiatives that target NTDs. These initiatives often involve
partnerships with affected regions to improve diagnosis and treatment.
The Asia-pacific region witnesses the fastest
growth in the Global Neglected Tropical Diseases Diagnosis Market. The
Asia-Pacific region is home to a significant proportion of the global NTDs
burden. Countries in this region are affected by a range of NTDs, including
lymphatic filariasis, schistosomiasis, soil-transmitted helminthiasis, and
others. The prevalence of these diseases drives the demand for diagnostic
tools. The Asia-Pacific region has a vast and densely populated demographic.
The sheer number of people at risk of NTDs translates into a substantial market
for diagnostic tests and services. Many countries in the Asia-Pacific region
have experienced significant economic growth and development in recent years.
This growth has led to increased investments in healthcare infrastructure,
including diagnostic capabilities. Rapid urbanization in the region has led to
improved healthcare access in urban areas, increasing the demand for diagnostic
services. However, rural areas may still face challenges in access to
healthcare. Several governments in the Asia-Pacific region have recognized the
importance of addressing NTDs and have implemented NTD control and elimination
programs. These programs often include efforts to strengthen diagnostic
capacities.
Some of the major companies
operating in the Global Neglected Tropical Diseases Diagnosis Market
include:
- F. Hoffmann-La Roche Ltd
- Abbott
- Thermo Fisher Scientific Inc.
- ZeptoMetrix
- InBios International, Inc.
- DiaSys Diagnostics Systems GmbH
- Genome Diagnostics Pvt. Ltd.
- Omega Diagnostics Group Plc
- Oscar Medicare Pvt Ltd.
- Coris BioConcept
Download Free Sample Report
Customers can also request 10% free
customization on this report.
“Certain
areas, particularly in North America, are projected to exert significant demand
for Neglected Tropical Diseases Diagnosis. The growth in the competitive
landscape and the presence of well-established companies in the market, committed
to enhance the overall wellbeing of people each year, are expected to
contribute to a remarkable growth of the Global Neglected Tropical Diseases
Diagnosis Market in the forecast period," said Mr. Karan Chechi, Research
Director with TechSci Research, a research-based Global management consulting
firm.
Neglected Tropical Diseases Diagnosis Market – Global Industry Size,
Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Disease (Dengue, Chikungunya, Rabies, Buruli Ulcer, Yaws, Lymphatic
Filariasis, Taeniasis/Cysticercosis, Dracunculiasis, others), By Diagnostic Method (Conventional, Molecular/Modern),
By Service Type (Centralized Service, POC Service), By End Use (Clinical Labs, Hospital/Clinics,
Home Healthcare), by region, and Competition evaluated the future growth potential of Global
Neglected Tropical Diseases Diagnosis Market and provides statistics &
information on market size, structure, and future market growth. The report
intends to provide innovative market intelligence and help decision makers take
sound investment decisions. Besides, the report also identifies and analyzes
the emerging trends along with essential drivers, challenges, and opportunities
in Global Neglected Tropical Diseases Diagnosis Market.
Contact
Techsci Research LLC
420 Lexington Avenue
Suite 300, New York
United States- 10170
M: +13322586602
Email: [email protected]
Web: https://www.techsciresearch.com